Edition:
United States

Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

34.82USD
18 Aug 2017
Change (% chg)

$-0.67 (-1.89%)
Prev Close
$35.49
Open
$35.12
Day's High
$35.59
Day's Low
$34.68
Volume
201,709
Avg. Vol
302,514
52-wk High
$36.95
52-wk Low
$24.47

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Fuad El-Hibri

59 2012 Executive Chairman of the Board

Daniel Abdun-Nabi

57 2012 President, Chief Executive Officer, Director

Robert Kramer

59 2012 Chief Financial Officer, Executive Vice President, Administration, Treasurer

Adam Havey

46 2017 Executive Vice President - Business Operations

Ronald Richard

61 2014 Lead Independent Director